Mucopolysaccharidosis type II, Iduronate sulfatase deficiency

The U.S. Food and Drug Administration has approved the first treatment for Hunter syndrome. The medicine, called idursulfase (Elaprase), is given through a vein (intravenously). Talk to your doctor for more information.

Bone marrow transplant has been tried for the early-onset form, but the results can vary.

Each health problem should be treated separately.

People with the early-onset (severe) form usually live for 10 - 20 years. People with the late-onset (mild) form usually live 20 - 60 years.

• Airway obstruction
• Carpal tunnel syndrome
• Hearing loss that gets worse over time
• Loss of ability to complete daily living activities
• Joint stiffness that leads to contractures
• Mental function that gets worse over time

Call your health care provider if:

• You or your child has a group of these symptoms
• You know you are a genetic carrier and are considering having children

Previous Section

Hunter syndrome Symptoms

Next Section

Hunter syndrome Prevention

Review Date: 05/16/2011
Reviewed By: Chad Haldeman-Englert, MD, Wake Forest School of Medicine, Department of Pediatrics, Section on Medical Genetics, Winston-Salem, NC. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)